Effects of Hepatic Impairment on the Pharmacokinetics of Dazucorilant

Clinical trial NCT06928779 · COMPLETED

Trial details

NCT number: NCT06928779
Sponsor: Corcept Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2024-10-08
Primary completion: 2024-12-09
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.